Question 1

What is Sodium Picosulfate, Magnesium Oxide, and Anhydrous Citric Acid used for?

Accepted Answer

Sodium Picosulfate, Magnesium Oxide, and Anhydrous Citric Acid helps dissolve or prevent formation of calculi (stones).

Question 2

Is there a generic for Sodium Picosulfate, Magnesium Oxide, and Anhydrous Citric Acid?

Accepted Answer

No. Sodium Picosulfate, Magnesium Oxide, and Anhydrous Citric Acid is brand-only with no generic equivalents currently in market.

Question 3

How much does my plan pay for Sodium Picosulfate, Magnesium Oxide, and Anhydrous Citric Acid?

Accepted Answer

Across 329 Part D plans, Sodium Picosulfate, Magnesium Oxide, and Anhydrous Citric Acid averages $0.518/unit (NADAC). Lowest available: $0.518/unit. Highest in distribution: $0.518/unit.

Question 4

Is Sodium Picosulfate, Magnesium Oxide, and Anhydrous Citric Acid on the FDA shortage list?

Accepted Answer

No. Sodium Picosulfate, Magnesium Oxide, and Anhydrous Citric Acid is not currently on the FDA Drug Shortage Database.

Question 5

What drug class is Sodium Picosulfate, Magnesium Oxide, and Anhydrous Citric Acid in?

Accepted Answer

Sodium Picosulfate, Magnesium Oxide, and Anhydrous Citric Acid is in the Calculi Dissolution Agent class. See related drugs in this class at /class/calculi-dissolution-agent.

Question 6

What is the brand name for Sodium Picosulfate, Magnesium Oxide, and Anhydrous Citric Acid?

Accepted Answer

Sodium Picosulfate, Magnesium Oxide, and Anhydrous Citric Acid is sold under the brand name CLENPIQ.

Question 7

Is CLENPIQ the same as Sodium Picosulfate, Magnesium Oxide, and Anhydrous Citric Acid?

Accepted Answer

Yes. CLENPIQ is a brand name for Sodium Picosulfate, Magnesium Oxide, and Anhydrous Citric Acid. The generic version is identical in active ingredient, dose, and FDA-approved indications. Pricing differs substantially: generic Sodium Picosulfate, Magnesium Oxide, and Anhydrous Citric Acid typically prices well below brand CLENPIQ.

Question 8

Why is Sodium Picosulfate, Magnesium Oxide, and Anhydrous Citric Acid on Tier 3 across most plans?

Accepted Answer

Sodium Picosulfate, Magnesium Oxide, and Anhydrous Citric Acid appears on Tier 3 in 38 plan-NDC pairs and Tier 1 in only 5. The reason is structural: PBM rebate guarantees on brand-tier placement reduce the PBM's incentive to move the molecule to a lower tier even when generic competition exists. Moving to Tier 1 is typically possible only at plan-year reset or via contract renegotiation.

Question 9

What can I switch to instead of Sodium Picosulfate, Magnesium Oxide, and Anhydrous Citric Acid?

Accepted Answer

Same-class alternatives include: Anhydrous Citric Acid, Dextrose Monohydrate, and Trisodium Citrate, Anhydrous Citric Acid, Trisodium Citrate Dihydrate, Sodium Phosphate, Monobasic, Monohydrate, Dextrose Monohydrate, and Adenine, Anticoagulant Citrate Dextrose (Acd). Whether substitution is clinically appropriate depends on patient indication, dose schedule, and contraindications — that is a P&T committee decision. The federal data shows cost and competition; clinical equivalence is not asserted here.

Question 10

When was Sodium Picosulfate, Magnesium Oxide, and Anhydrous Citric Acid first FDA approved?

Accepted Answer

Sodium Picosulfate, Magnesium Oxide, and Anhydrous Citric Acid received its first FDA approval on 2023-03-29.

Sodium Picosulfate, Magnesium Oxide, and Anhydrous Citric Acid (CLENPIQ)

Questions a plan sponsor actually asks.

Related questions.

Same class. Different math.

Sources · every number above traces back.